[Report of 276 Pages] The market for insulin delivery pens is anticipated to reach US$ 22.4 billion by the end of 2022 and continue to grow at a CAGR of 8.0% to reach US$ 48.6 billion by the end of 2032. In 2021, smart insulin pens held a market share of approximately 34.6%, according to a recent …
Category Archives: Healthcare Trends
Rosai-Dorfman Disease (RDD) Therapeutics Market value of US$ 431 Million in 2023 | Exclusive Report by FMI
During the forecast period 2023 to 2033, the Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Rosai-Dorfman Disease (RDD) Therapeutics is expected to rise up to a market valuation of US$ 839.95 Million. The global RDD therapeutics …
Live Cell RNA Detection Market is projected to reach US$ 6,404.2 million by 2032, with a CAGR of 8.4%
The market for detecting RNA in living cells is projected to experience significant growth, with demand expected to reach US$ 2,631.8 million in 2022 and rise at a compound annual growth rate (CAGR) of 8.4% to reach US$ 6,404.2 million by 2032. RNA is crucial for cell and tissue development, as well as disease progression, …
Embryo Incubator Market is expected to garner a value of US$ 132.9 million by 2032, with a CAGR of 5%
The global embryo incubator market size is expected to be worth US$ 77.8 million in 2022 and US$ 132.9 million by 2032, with a 5% CAGR from 2022 to 2032. The market’s rise can be attributed to an increase in the usage of in-vitro fertilisation methods to aid in reproduction among patients. The embryo is …
Gastric Electrical Stimulators Market is likely to register CAGR of 6.2% through 2032
The market for global gastric electrical stimulators is projected to reach a value of US$ 227.8 million in 2022, driven by the growing availability of high-frequency gastric electrical stimulators and increased focus on managing chronic illnesses like gastroparesis. The market is expected to expand at a strong CAGR of 6.2% between 2022 and 2032, with …
Congenital Hyperinsulinism Treatment Market is projected to reach US$ 179.08 million by 2033, at a CAGR of 6%
According to projections, the global market for congenital hyperinsulinism treatment is set to reach US$ 100 million by 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6% from 2023 to 2033, accumulating a market value of US$ 179.08 million. Between 2017 and 2022, the market recorded a CAGR of …
Restrictive Cardiomyopathy Treatment Market is anticipated to reach US$ 21.05 Billion by 2033, at a CAGR of 13%
The restrictive cardiomyopathy treatment market size is projected to reach a value of US$ 6.2 Billion by 2023, with a forecasted CAGR of 13% from 2023 to 2033, resulting in an estimated market value of US$ 21.05 Billion. In the historical period from 2018 to 2022, the market witnessed a CAGR of 10%. The growth …
Heterozygous Familial Hypercholesterolemia (HEFH) Management Market value is expected to reach US$ 58.54 Billion by 2033
The market for managing heterozygous familial hypercholesterolemia (HEFH) management is expected to reach a value of US$ 15.11 billion in fiscal year 2023, up from US$ 13.2 billion in 2022. The market is predicted to grow at a steady CAGR of 14.5% from 2023 to 2033, with an estimated value of US$ 58.54 billion by …
Progressive Multifocal Leukoencephalopathy Treatment Market is expected to grow with a 3% CAGR from 2023 to 2033
The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of US$ 1,320 million in 2023 and is expected to accumulate a market value of US$ 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoencephalopathy treatment registered a CAGR of 2% …
Spinal Osteosynthesis Units Market to grow at a CAGR of around 4.8% over the assessment period 2022 to 2032
[Report of 250 Pages] Around US$ 2.8 billion was spent on spinal osteosynthesis units globally in 2021. The market is anticipated to grow at a steady CAGR of 4.8% between 2022 and 2032, surpassing US$ 3.9 Billion by that year due to the rapid increase in spinal surgeries and rising incidence of spinal conditions like lumbar spondylosis, …